New Jersey S 1030: Permits certain managed care organizations to consider cost-effectiveness when placing prescription drug on formulary.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2022-01-31)

State: New Jersey · Session: 220 · Bill: S 1030

Subjects: PHARMACEUTIC

Sponsors: Singleton, Troy

View New Jersey S 1030 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.